Cardioprotection with sildenafil, a selective inhibitor of cyclic 3′,5′-monophosphate-specific phosphodiesterase 5

Drugs under Experimental and Clinical Research

Volumn 28, Issue 6, 2002, Pages 213-219

  Das, S ^a   Maulik, N ^a   Das, D K ^a   Kadowitz, P J ^b   Bivalacqua, T J ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V; SILDENAFIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA FLOW; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; HEART VENTRICLE FIBRILLATION; ISOLATED HEART; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; CARDIOTONIC AGENTS; CYCLIC GMP; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION;

EID: 0037904833     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker, P.A. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N. Engl. J. Med., 338, 1397, 1998.
2. Cheitlin M.D., Hutter A.M.J., Brindis R.G., et al. ACC/AHA consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart association J. Am. Coll. Cardiol., 33, 273, 1999.
3. Maulik N., Engelman D.T., Watanabe M., et al. Nitric oxide signaling in ischemic heart. Cardiovasc. Res., 30, 593, 1995.
4. Doherty P.C., Bivalacqua T.J., Champion H.C., et al. Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats. J. Urol., 165, 1004, 2001.
5. Burger M., Sikka S.C., Bivalacqua T.J., Lamb D.J., Hellstrom W.J. The effect of sildenafil on human sperm motion and function from normal and infertile men. Int. J. Impot. Res., 12, 229, 2000.
6. Engelman D.T., Watanabe M., Engelman R.M., et al. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc. Res., 29, 133, 1995.
7. Tosaki A., Hellegouarch A. Adenosine triphosphate-sensitive potassium channel blocker ameliorates, but the opener aggravates ischemia/reperfusion-induced injury: Heart function studies in nonfibrillating isolated hearts. J. Am. Coll. Cardiol., 23, 487, 1994.
8. Sato M., Cordis G.A., Maulik N., Das D.K. SAPKs regulation of ischemic preconditioning Am. J. Physiol., 279, H901, 2000.
9. Katz S.D., Balidemaj K., Homma S., Wu H, Wang, J., Maybaum S. Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure J. Am. Coll. Cardiol., 36, 845, 2000.
10. Zusman R.M., Morales A., Glasser D. B., Osterloh I.H. Overall cardiovascular profile of sildenafil citrate. Am. J. Cardiol., 83, 35, 1999.
11. Otani H., Otani H., Das D.K. Al-adrenoceptor-mediated phosphoinositide break-down and inotropic response in rat left ventricular papillary muscles. Circ. Res., 62, 8, 1988.
12. Maulik N., Engelman D., Watanabe M., et al. Nitric oxide/carbon monoxide: A free radical-dependent molecular switch for myocardial preservation during ischemic arrest. Circulation, 94, 407, 1996.
13. Murad F. Regulation of cytosolic guanylyl cyclase by nitric oxide: The NO-cGMP signal transduction system. Adv. Pharmacol., 26, 19, 1994.
14. + channels mediate an endothelium dependent hyperpolarization in rabbit mesenteric arteries. J. Physiol., 489 (Pt. 3), 723, 1995.
15. Suzuki M., Sasaki N., Miki T., et al. Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J. Clin. Invest., 109, 509, 2002.
16. Lin R.-J., Wu B.-N., Lo Y.-C., et al. KMUP relaxes rabbit corpus cavernosum smooth muscle in vitro and in vivo: Involvement of cyclic GMP and K+ channels. Brit. J. Pharmacol., 135, 1159, 2002.